Aims & Scope

Aims:

Clinical Neuropsychopharmacology and Addiction (CNA) is a peer-reviewed, gold open-access journal committed to advancing the science and practice of neuropsychopharmacology and addiction medicine. CNA aims to publish high-quality, cutting-edge research that explores the psychopharmacological treatment of neuropsychiatric disorders, substance use disorders, and behavioral addictions, fostering innovation and interdisciplinary collaboration in these critical areas. It is published quarterly online by Scilight Press.

Scope:

Clinical Neuropsychopharmacology and Addiction (CNA) serves as a comprehensive platform for publishing original research, reviews, and clinical case studies addressing key topics in psychopharmacology and addiction science. The journal’s scope includes:

  • Psychopharmacological treatments for psychosis, unipolar depression, bipolar disorder, alcohol and substance use disorders, as well as other major psychiatric conditions. Contributions focusing on psychopharmacological approaches to dementia, Parkinson’s disease, and movement disorders are also encouraged.
  • Investigations into the fundamental mechanisms through which pharmacological treatments exert their effects, including studies employing neuroimaging techniques and preclinical research.
  • A dedicated focus on dual disorders and comorbidities, exploring the complex interplay between psychiatric conditions and addiction.
  • Research covering all stages of addiction—intoxication, withdrawal, relapse prevention, and craving management—emphasizing innovative and effective therapeutic strategies.
  • Studies on behavioral addictions and novel psychoactive substances, with an emphasis on their neurobiological and psychosocial mechanisms.
  • Research addressing neuropsychiatric disorders, including autism and ADHD, focusing on their psychopathological features and novel treatment approaches.
  • Phenomenological evaluations of clinical symptoms to refine diagnostic accuracy and guide personalized therapeutic approaches, particularly at the intersection of psychopathology and psychopharmacology.
  • The role of environmental and social factors in the onset and progression of neuropsychiatric diseases, exploring their influence on etiology, neurobiology, and treatment outcomes.

CNA fosters interdisciplinary research spanning psychiatry, pharmacology, neuroscience, and clinical psychology, particularly targeting the challenges of complex cases involving comorbidities. Submissions must present significant advancements in understanding and treating neuropsychiatric disorders and addiction, ensuring their relevance to clinicians, researchers, and policymakers.

By advancing a personalized, evidence-based approach to treatment, CNA aims to improve patient outcomes and inspire innovation in neuropsychopharmacology and addiction science.

The journal welcomes original research articles, including case studies and systematic reviews, while narrative reviews and opinion pieces are considered by invitation from the Editorial Office.